Form 4 Tracker
Curtis Gale Oltmans

Chief Legal Officer · 1 filing · Latest: Feb 2, 2026

Fulcrum Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
FULC
CURTIS G OLTMANSDec 15, 2025
Proposed Sale
$13.003,452$44.9K